Role of annexin A5 on mitochondria-dependent apoptosis induced by tetramethoxystilbene in human breast cancer cells

Biomolecules and Therapeutics

Volumn 22, Issue 6, 2014, Pages 519-524

  Hong, Mihye ^a   Park, Nahee ^a   Chun, Young Jin ^a  

^a Chung Ang University   (South Korea)

Author keywords

Annexin A5; Bax; Tetramethoxystilbene; VDAC1

Indexed keywords

2,4,3',5' TETRAMETHOXYSTILBENE; APOPTOSIS INDUCING FACTOR; CYTOCHROME C; LIPOCORTIN 5; PROTEIN BAK; PROTEIN BAX; SMALL INTERFERING RNA; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OLIGOMERIZATION; PROTEIN EXPRESSION;

EID: 84912575615     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2014.112     Document Type: Article

References (15)

1. Chun, Y. J., Kim, S., Kim, D., Lee, S. K. and Guengerich, F. P. (2001) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res. 61, 8164- 8170.
2. Chun, Y. J. and Kim, S. (2003) Discovery of cytochrome P450 1B1 inhibitors as new anti-cancer agents. Med. Res. Rev. 23, 657-668.
3. Chun, Y. J., Lee, S. K. and Kim, M. Y. (2005) Modulation of human cytochrome P4501B1 expression by 2,4,3',5'-tetramethoxystilbene. Drug Metab. Dispos. 33, 1771-1776.
4. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J. and Sutter, T. R. (1996) 17b-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781.
5. Jeong, J. J., Park, N., Kwon, Y. J., Ye, D. J., Moon, A. and Chun, Y. J. (2014) Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis. J. Biol. Chem. 289, 2469-2481.
6. kip1by 2,4,3',5'-tetramethoxystilbene is regulated by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. Arch. Pharm. Res. 31, 1187-1194.
7. Kwon, Y. J., Jung, J. J., Park, N. H., Ye, D. J., Kim, D., Moon, A. and Chun, Y. J. (2013) Annexin A5 as a new potential biomarker for cisplatin-induced toxicity in human kidney epithelial cells. Biomol. Ther. 21,190-195.
8. Liehr, J. G. (1997) Dual role of oestrogens as hormones and procarcinogens: tumor initiation by metabolic activation of oestrogens. Eur. J. Cancer Prev. 6, 3-10.
9. Ravagnan, L., Roumier, T. and Kroemer, G. (2002) Mitochondria, the killer organelles and their weapons. J. Cell. Physiol. 192, 131-137.
10. Rothhut, B., Dubois, T., Feliers, D., Russo-Marie, F. and Oudinet, J. P. (1995) Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur. J. Biochem. 232, 865-872.
11. Shimada, T., Gillam, E. M. J., Sutter, T. R., Strickland, P. T., Guengerich, F. P. and Yamazaki, H. (1997) Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos. 25, 617-622.
12. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P. and Sutter, T. R. (1996) Activation of chemically diversed procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.
13. Shimada, T., Watanabe, J., Kawajiri, K., Sutter, T. R., Guengerich, F. P., Gillam, E. M. J. and Inoue, K. (1999) Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20,1607-1613.
14. Tajeddine, N., Galluzzi, L., Kepp, O., Hangen, E., Morselli, E., Senovilla, L., Araujo, N., Pinna, G., Larochette, N., Zamzami, N., Modjtahedi, N., Harel-Bellan, A. and Kroemer, G. (2008) Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 27, 4221-4232
15. van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B. and Reutelingsperger, C. P. (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9.